Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Controversies on individualized prostate cancer care: gaps in current practice.

Joniau S, Pfister D, de la Taille A, Gaboardi F, Thompson A, Ribal MJ.

Ther Adv Urol. 2013 Oct;5(5):233-44. doi: 10.1177/1756287213490053.

2.

Evidence Brief: Effectiveness of Intensive Primary Care Programs.

Peterson K, Helfand M, Humphrey L, Christensen V, Carson S.

VA Evidence-based Synthesis Program Evidence Briefs [Internet]. Washington (DC): Department of Veterans Affairs (US); 2011-.
2013 Feb.

3.

EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.

Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N; European Association of Urology..

Eur Urol. 2014 Jan;65(1):124-37. doi: 10.1016/j.eururo.2013.09.046.

PMID:
24207135
4.

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N; European Association of Urology..

Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Review.

PMID:
24321502
5.

Evidence Brief: The Quality of Care Provided by Advanced Practice Nurses.

McCleery E, Christensen V, Peterson K, Humphrey L, Helfand M.

VA Evidence-based Synthesis Program Evidence Briefs [Internet]. Washington (DC): Department of Veterans Affairs (US); 2011-.
2014 Sep.

6.

Patient-Provider Communication About Prostate Cancer Screening and Treatment: New Evidence From the Health Information National Trends Survey.

Bhuyan SS, Chandak A, Gupta N, Isharwal S, LaGrange C, Mahmood A, Gentry D.

Am J Mens Health. 2015 Nov 26. pii: 1557988315614082. [Epub ahead of print]

PMID:
26614441
7.

A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.

Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR.

Eur Urol. 2014 Sep;66(3):550-60. doi: 10.1016/j.eururo.2014.05.004.

8.

A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.

Dahm P, Yeung LL, Chang SS, Cookson MS.

J Urol. 2008 Aug;180(2):451-9; discussion 460. doi: 10.1016/j.juro.2008.04.004. Review.

PMID:
18550100
9.

Individualized decision-making for older men with prostate cancer: balancing cancer control with treatment consequences across the clinical spectrum.

Sajid S, Mohile SG, Szmulewitz R, Posadas E, Dale W.

Semin Oncol. 2011 Apr;38(2):309-25. doi: 10.1053/j.seminoncol.2011.01.011. Review.

PMID:
21421119
10.

Effects of Nurse-Managed Protocols in the Outpatient Management of Adults with Chronic Conditions [Internet].

Shaw RJ, McDuffie JR, Hendrix CC, Edie A, Lindsey-Davis L, Williams JW Jr.

Washington (DC): Department of Veterans Affairs; 2013 Aug.

12.

Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting.

De Bari B, Fiorentino A, Greto D, Ciammella P, Arcangeli S, Avuzzi B, D'Angelillo RM, Desideri I, Kirienko M, Marchiori D, Massari F, Fundoni C, Franco P, Filippi AR, Alongi F.

Tumori. 2013 Nov-Dec;99(6):637-49. doi: 10.1700/1390.15450. Erratum in: Tumori. 2014 May-Jun;100(3):e98.

PMID:
24503785
13.
14.

EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.

van de Velde CJ, Boelens PG, Borras JM, Coebergh JW, Cervantes A, Blomqvist L, Beets-Tan RG, van den Broek CB, Brown G, Van Cutsem E, Espin E, Haustermans K, Glimelius B, Iversen LH, van Krieken JH, Marijnen CA, Henning G, Gore-Booth J, Meldolesi E, Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A, Rutten H, Schmoll HJ, Smith JJ, Tanis PJ, Taylor C, Wibe A, Wiggers T, Gambacorta MA, Aristei C, Valentini V.

Eur J Cancer. 2014 Jan;50(1):1.e1-1.e34. doi: 10.1016/j.ejca.2013.06.048.

PMID:
24183379
15.

[Consensus-based guidelines on prostate biopsy].

Italian Panel on Prostate Biopsy..

Arch Ital Urol Androl. 2005 Sep;77(3 Suppl 1):1-2, preceding 1. Italian.

PMID:
16402723
16.

[Interdisciplinary and individualized therapy of prostate cancer : International prostate cancer symposium Bonn 2013 - challenges and targets].

Schwardt M, Debus J, Feick G, Hadaschik B, Hohenfellner M, Schüle R, Zacharias JP, Combs SE.

Urologe A. 2015 Nov;54(11):1584-90. doi: 10.1007/s00120-014-3580-7. German.

PMID:
25297487
17.
18.

ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer.

Moran BJ, DeRose P, Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Rosenthal SA, Rossi CJ Jr, Yamada Y, Merrick GS.

Am J Clin Oncol. 2011 Dec;34(6):636-47. doi: 10.1097/COC.0b013e3182354a65. Review.

PMID:
22101389
19.

Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach.

Fitzpatrick JM, Anderson J, Sternberg CN, Fleshner N, Fizazi K, Rébillard X, Dogliotti L, Conti G, Turesson I, James N, Heidenreich A, Solsona E, Guillem V, Herchenhorn D, Moul J, van Moorselaar J, Coetzee LJ, Wilson A, Bamias A, De Wit R, Chrisofos M.

Crit Rev Oncol Hematol. 2008 Oct;68 Suppl 1:S9-S22. doi: 10.1016/j.critrevonc.2008.07.019. Review.

PMID:
18723368
20.

Clinician-led improvement in cancer care (CLICC)--testing a multifaceted implementation strategy to increase evidence-based prostate cancer care: phased randomised controlled trial--study protocol.

Brown BB, Young J, Smith DP, Kneebone AB, Brooks AJ, Xhilaga M, Dominello A, O'Connell DL, Haines M.

Implement Sci. 2014 May 29;9:64. doi: 10.1186/1748-5908-9-64.

Supplemental Content

Support Center